Zhejiang Xianju Pharmaceutical Co., Ltd.

Zhejiang Xianju Pharmaceutical Co., Ltd. is a comprehensive manufacturer specializing in the research, development, production, and sales of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). The company primarily focuses on steroidal APIs and FDFs, with its product offerings categorized into corticosteroids, sex hormones, and anesthesia and muscle relaxants. Established in 2010 and listed on the Shenzhen Stock Exchange, Zhejiang Xianju has positioned itself as a key player in the pharmaceutical manufacturing sector in China. The company's main business lines include the production of corticosteroids such as Dexamethasone, Prednisone, and Triamcinolone, alongside sex hormones like Progestogens and estrogens. It also produces various anesthesia and muscle relaxants. Zhejiang Xianju employs a rigorous production process that adheres to Good Manufacturing Practices (GMP) and maintains strict quality control throughout its operations. The company has developed a robust sales network, covering major hospitals and pharmacies across China, and utilizes multiple sales modes including terminal sales, investment agency, and dealer agency lines to effectively reach its market.

The company is a professional steroidal drug manufacturer in China, it is a national high-tech enterprise, and also one of China's top 100 pharmaceutical enterprises. The company is leading the domestic pharmaceutical industry in the optimization of production process and cost control of production. 1. The company has sufficient R&D technology reserves and has cooperated with many domestic research institutes to continuously develop and introduce new technologies and new products, train scientific research personnel, set up enterprise research institutes and attract advanced scientific research talents, and develop new high-tech technical products in line with international new drug development. 2. The company has mature marketing mode, and has developed two complete sales networks for hospital line and OTC line, and explored an effective terminal management and marketing strategies. The sales network of the company's hospital line has covered major hospitals above prefecture-level cities in China. The number of pharmacies administered by OTC line salespeople has reached more than 60,000. 3. The internal management mechanism of the company has effectively matched the objective reality. The core team structure of the company is stable with more than 10 years work experience in the field of pharmaceutical production or sales . The team also has rich experience in the core field of the company's business and is familiar with the market economic rules and modern management principles.